Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 25/11/20201 min de leitura
Termination of the Food and Drug Administration's Unapproved Drugs Initiative; Request for Information Regarding Drugs Potentially Generally Recognized as Safe and Effective
Tradução automática local · Idioma original da fonte
Resumo
The Department of Health and Human Services is issuing this Notice to withdraw FDA's Marketed Unapproved Drugs--Compliance Policy Guide, Sec. 440.100, Marketed New Drugs Without Approved NDAs or ANDAs, and to request information from the public regarding drugs that may be grandfathered or generally recognized as safe and effective.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →